HÜRMÜZ, P. Et Al. 2021. Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1 , 1-7.

HÜRMÜZ, P., BEDÜK ESEN, Ç. S., Unal, E., KARÇAALTINCABA, M., ÖZYİĞİT, G., & AKYOL, H. F., (2021). Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1, 1-7.

HÜRMÜZ, PERVİN Et Al. "Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1, 1-7, 2021

HÜRMÜZ, PERVİN Et Al. "Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1, pp.1-7, 2021

HÜRMÜZ, P. Et Al. (2021) . "Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.31, no.1, pp.1-7.

@article{article, author={PERVİN HÜRMÜZ Et Al. }, title={Does Intravesical Prostatic Protrusion Affect Oncological Outcomes and Toxicity in Prostate Cancer Patients Receiving Definitive Radiotherapy?}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2021, pages={1-7} }